Longitudinal Cortical Thickness Changes in GBA-Positive Parkinson’s Disease (2696)
Article 2021 en
Authors
ML
Michela Leocadi
FA
Federica Agosta
EC
Elisa Canu
Abstract
1 min read
The aim of this study was to assess the longitudinal disease course of Parkinson’s disease (PD) patients with glucocerebrosidase (GBA) gene mutation (GBA-positive) compared to GBA-negative patients along a 5-year follow-up, evaluating changes in cortical thickness and clinical outcomes.
Discussion(0)
No comments yet. Be the first to comment.